查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區新生兒篩檢市場預測至 2030 年 - 區域分析 - 按產品類型（試劑和檢測試劑盒及儀器）、技術、測試類型和最終用戶（醫院和診所以及診斷實驗室）
市場調查報告書
商品編碼
1463687

亞太地區新生兒篩檢市場預測至 2030 年 - 區域分析 - 按產品類型（試劑和檢測試劑盒及儀器）、技術、測試類型和最終用戶（醫院和診所以及診斷實驗室）

Asia Pacific Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日期: | 出版商: The Insight Partners | 英文 107 Pages | 訂單完成後即時交付

價格

2022年亞太新生兒篩檢市場價值為2.7013億美元，預計到2030年將達到6.0214億美元；預計2022年至2030年CAGR為10.5%。

新生兒基因篩檢推動亞太新生兒篩檢市場的發展。

隨著人們對疾病遺傳原因的認知不斷加深以及醫療保健技術的進步，對新生兒進行全面基因篩檢的需求正在增加。因此，新生兒篩檢市場的公司正在開發創新、經濟高效的篩檢解決方案。 Yescarta 和 Zynteglo 是針對大 B 細胞淋巴瘤和 BETA 地中海貧血的授權基因治療的兩個例子。此外，技術的出現賦予了識別出生時疾病遺傳傾向的能力，為個人化醫療保健鋪平了道路，與精準醫療的更廣泛趨勢保持一致。

孕期遺傳疾病篩檢的重點還在於及早發現與妊娠相關的問題。新一代定序有助於新生兒產前篩檢，檢測所有染色體的非整倍體（如唐氏症和 21 三體性）或部分染色體異常（重複或缺失）的敏感度超過 95%。螢光原位雜合技術（FISH）用於檢測鐮狀細胞性貧血等單基因疾病；它還有助於有效的植入前遺傳學診斷。使用母體血漿進行無細胞胎兒 DNA 等非侵入性操作是基因檢測的最新進展。胚胎 DNA 可以根據大小差異與母體 DNA 片段區分開來。使用螢光探針的即時 PCR、鳥槍定序（Solexa 或 Illumina）或大規模標靶平行定序可用於檢查與胎兒健康狀況相關的 DNA。如果進一步研究這種類型的基因篩檢，這將使醫生能夠透過某些藥物療法（藥物遺傳學）提供早期分子干涉，並在物理和化學上改造細胞、組織和器官。因此，嬰兒遺傳性疾病篩檢方法的進步為整個新生兒篩檢市場帶來了巨大的潛力。

亞太地區新生兒篩檢市場概況

亞太地區的新生兒篩檢市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。亞太地區新生兒篩檢市場分為日本、中國、印度、韓國、澳洲和亞太其他地區。預計亞太地區將成為 2022-2030 年全球新生兒篩檢市場成長最快的地區。該地區市場的預期成長可能與新生兒出生數量高、先天性疾病盛行率飆升、對新生兒出生缺陷早期診斷的認知不斷提高以及致力於為新生兒提供更好解決方案的組織的存在有關。篩選。

亞太地區新生兒篩檢日益受到關注；由於出生率高，中國、印度等國家的政府機構需要實施新生兒篩檢計畫。根據聯合國國際兒童緊急基金會（UNICEF）的數據，印度每天有 67,385 名嬰兒出生，佔全球單日分娩人數的六分之一。此外，印度已成為人口最多的國家；根據 Worldmapper 的數據，2022 年約有 2,300 萬名嬰兒出生，其次是中國，出生人數為 1,000 萬人。隨著出生率的不斷飆升，印度以及亞太地區其他國家對嬰兒照護的關注日益增加。

亞太地區新生兒篩檢市場收入及 2030 年預測（百萬美元）

亞太地區新生兒篩檢市場細分

亞太地區新生兒篩檢市場根據產品類型、技術、測試類型、最終用戶和國家進行細分。

根據產品類型，亞太地區新生兒篩檢市場分為試劑、檢測試劑盒和儀器。到 2022 年，試劑和檢測試劑盒細分市場將佔據更大的亞太新生兒篩檢市場佔有率。儀器部分細分為新生兒疾病篩檢儀器、脈搏血氧儀、新生兒聽力篩檢儀器和其他儀器。

從技術面來看，亞太新生兒篩檢市場分為串聯質譜（TMS）、分子檢測、免疫檢測和酵素檢測、脈搏血氧篩檢技術等技術。 2022 年，脈搏血氧儀篩檢技術領域佔據亞太地區最大的新生兒篩檢市場。

根據測試類型，亞太新生兒篩檢市場分為乾血斑測試、聽力篩檢測試、危重先天性心臟病（CCHD）測試和其他測試類型。 2022 年，乾血斑檢測領域佔據亞太地區最大的新生兒篩檢市場。

依最終用戶分類，亞太地區新生兒篩檢市場分為醫院、診所和診斷實驗室。到 2022 年，醫院和診所細分市場將佔據更大的亞太新生兒篩檢市場。

按國家/地區分類，亞太地區新生兒篩檢市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022年，中國在亞太新生兒篩檢市場佔據主導地位。

Bio-Rad Laboratories Inc、LifeCell International Pvt Ltd、Masimo Corp、Medtronic Plc、Natus Medical Inc、PerkinElmer Inc、Trivitron Healthcare Pvt Ltd 和 Waters Corp 是亞太新生兒篩檢市場上的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區新生兒篩檢市場 - 主要產業動態

  • 主要市場促進因素
    • 政府為新生兒篩檢提供的資金激增
    • 先天性疾病負擔不斷增加
    • 新生兒疾病盛行率不斷增加
  • 主要市場限制
    • 新生兒篩檢政策和實踐缺乏統一
  • 主要市場機會
    • 新生兒基因篩檢
  • 未來的趨勢
    • 機器學習和人工智慧在篩檢中的整合
  • 影響分析：

第 5 章：新生兒篩檢市場 - 亞太市場分析

  • 2022 - 2030 年亞太地區新生兒篩檢市場收入

第 6 章：亞太地區新生兒篩檢市場 - 2030 年收入和預測 - 按產品類型

  • 概述
  • 2022 年及 2030 年亞太地區新生兒篩檢市場收入佔有率（按產品類型分類）（%）
  • 試劑和檢測試劑盒
  • 儀器

第 7 章：亞太地區新生兒篩檢市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年及 2030 年亞太地區新生兒篩檢市場收入佔有率（按技術分類）（%）
  • 串聯質譜 (TMS)
  • 分子檢測
  • 免疫測定和酵素測定
  • 脈搏血氧篩檢技術
  • 其他技術

第 8 章：亞太地區新生兒篩檢市場 - 2030 年收入和預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年亞太地區新生兒篩檢市場收入佔有率，按測試類型分類 (%)
  • 乾血斑測試
  • 聽力篩檢測試
  • 嚴重先天性心臟病 (CCHD) 測試
  • 其他測試類型

第 9 章：亞太地區新生兒篩檢市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年亞太地區新生兒篩檢市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診所
  • 診斷實驗室

第 10 章：亞太地區新生兒篩檢市場 - 國家分析

  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區

第 11 章：亞太地區新生兒篩檢市場-產業格局

  • 概述
  • 新生兒篩檢市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • LifeCell International Pvt Ltd
  • Trivitron Healthcare Pvt Ltd
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Medtronic Plc

第 13 章：附錄

Product Code: BMIRE00029605

The Asia Pacific newborn screening market was valued at US$ 270.13 million in 2022 and is expected to reach US$ 602.14 million by 2030; it is estimated to grow at a CAGR of 10.5% from 2022 to 2030.

Genetic Screening of Newborns Fuels the Asia Pacific Newborn Screening Market.

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. Yescarta and Zynteglo are two examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Asia Pacific Newborn Screening Market Overview

The newborn screening market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia -Pacific newborn screening market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia -Pacific. Asia -Pacific is expected to be the fastest-growing region in the global newborn screening market during 2022-2030. The projected growth of the market in this region can be associated with the high number of newborn births, the soaring prevalence of congenital diseases, rising awareness regarding early diagnosis of birth defects in newborns, and the presence of organizations working toward offering better solutions for newborn screening.

Screening of newborns in Asia -Pacific is gaining traction; government agencies in China, India, and other countries need to implement newborn screening programs owing to the high birth rate. According to the United Nations International Children's Emergency Fund (UNICEF), 67,385 babies are born in India each day, accounting for one-sixth of childbirths recorded globally in a day. In addition, India has become the most populated nation; as per Worldmapper, ~23 million babies were born in 2022, followed by China with the birth of 10 million babies. With the constantly soaring birth rate, the focus on infant care is increasing in India, as well as in other countries in Asia -Pacific.

Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Newborn Screening Market Segmentation

The Asia Pacific newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Asia Pacific newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Asia Pacific newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Asia Pacific newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Asia Pacific newborn screening market share in 2022.

Based on test type, the Asia Pacific newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Asia Pacific newborn screening market share in 2022.

By end user, the Asia Pacific newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Asia Pacific newborn screening market share in 2022.

Based on country, the Asia Pacific newborn screening market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific newborn screening market in 2022.

Bio-Rad Laboratories Inc, LifeCell International Pvt Ltd, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, Trivitron Healthcare Pvt Ltd, and Waters Corp are some of the leading companies operating in the Asia Pacific newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Asia Pacific Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Asia Pacific Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Newborn Screening Market - Country Analysis

  • 10.1 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Newborn Screening Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.1.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 India
        • 10.1.2.3.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.3.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.4.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.4.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.5.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.5.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Asia Pacific Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 LifeCell International Pvt Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Trivitron Healthcare Pvt Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 PerkinElmer Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Waters Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bio-Rad Laboratories Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Masimo Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Natus Medical Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Newborn Screening Market Segmentation
  • Table 2. Asia Pacific Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Asia Pacific Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. China Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. China Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Japan Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Japan Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Japan Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. India Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. India Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. India Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. India Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Australia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Australia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Australia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Australia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. South Korea Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. South Korea Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 | (US$ Million)
  • Table 31. South Korea Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. South Korea Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. South Korea Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Rest of Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 42. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Asia Pacific Newborn Screening Market Segmentation, By Country
  • Figure 2. Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Newborn Screening Market